ATTENTION

If you or someone you know is experiencing a mental health crisis, call 988 for 24/7 free and confidential crisis support. You do not have to be suicidal to call. Access more info and resources on suicide prevention, emotional and mental health support

toggle mobile menu Menu
toggle search menu

Site Navigation

Supplemental

Menu

Parkinson's Disease: Movement Problems From Levodopa

Parkinson's Disease: Movement Problems From Levodopa

Overview

Movement problems (motor fluctuations) are the most common complication of long-term levodopa use. The majority of people who take levodopa develop these problems within 5 to 10 years. The main types of levodopa-related motor fluctuations include:

The wearing-off effect.

Wearing-off periods occur when the effects of a single dose of levodopa do not last as long as they used to. Control of motor symptoms decreases as the effects of the medicine wear off. And symptoms do not improve until the next dose of levodopa is taken. These motor fluctuations are easy to predict based on the timing of each dose of medicine.

Dyskinesias.

Dyskinesias are sudden, uncontrollable, often jerky or writhing movements. They may affect the head, neck, arms, and legs or other parts of the body. Dyskinesias are especially common in younger people with Parkinson's disease.

The on-off response.

"On" and "off" periods occur without warning as a result of fluctuating dopamine levels in the brain. The symptoms are similar to the motor problems that occur as a result of the wearing-off effect. But the symptoms are harder to predict and harder to treat. An "off" period usually occurs suddenly, over seconds or minutes, and the person may freeze. In contrast, uncontrollable movements may occur during the "on" periods.

Motor fluctuations sometimes can be reduced or delayed by changing the schedule and amount of levodopa. Other medicines may be added to levodopa to help with motor fluctuations. Examples are dopamine agonists, COMT inhibitors, or MAO-B inhibitors. More and more, doctors are using dopamine agonists as the first treatment for Parkinson's disease, especially in younger people, to delay the development of motor fluctuations that eventually happen with long-term use of levodopa.

Related Information

Credits

Current as of: August 25, 2022

Author: Healthwise Staff
Medical Review:
Anne C. Poinier MD - Internal Medicine
Adam Husney MD - Family Medicine
Martin J. Gabica MD - Family Medicine
Kathleen Romito MD - Family Medicine
G. Frederick Wooten MD - Neurology

This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Healthwise is a URAC accredited health web site content provider. Privacy Policy. How this information was developed to help you make better health decisions.

© 1995- Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.